3Kastor JA. Michel Mirowski and the automatic implantable defibrillator. Am J Cardiol, 1989,63 : 1121-1126.
4(AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from nearfatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators(AVID) Investigators. N Engl J Med, 1997,337 : 1576-1583.
5Connolly SJ,Gent M, Roberts RS,et al. Canadian Implantable Defibrillator Study (CIDS):study design and organization. CIDS Co- Investigators. Am J Cardiol, 1993,72 : 103F-108F.
6Siebels J, Cappato R, Ruppel R, et al. Preliminary results of the Cardiac Arrest Study Hamburg(CASH). CASH Investigators. Am J Cardiol, 1993,72 : 109F-113F.
7Ellison KE, Harley GE, Hickey K, et al. Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial(MUST[). Circulation ,2002,106:2694-2699.
8Grimm W,Alter P, Maisch B. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT. Herz,2004,29:348-352.
9Vaughan Williams EM. Classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Olesen KH, eds. Symposium on cardiac arrhythmias. Elsinore, Denmark: Astra, 1970,449-472.
10Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian gambit:a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation, 1991,84 : 1831 -1851.
